DrugPatentWatch Database Preview
RITUXAN Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: RITUXAN
| Patents: | 774 |
| Applicants: | 2 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for RITUXAN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for RITUXAN |
Recent Clinical Trials for RITUXAN
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Rutgers, The State University of New Jersey | Phase 2 |
| AstraZeneca | Phase 2 |
| JDP Therapeutics, Inc. | Phase 2 |
Recent Litigation for RITUXAN
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. | 2019-07-12 |
| CELGENE CORPORATION v. APOTEX INC. | 2019-06-19 |
| Genentech, Inc. v. Pfizer Inc. | 2019-04-05 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Celltrion, Inc. | 2018-05-04 |
| 2018-02-23 | |
| 2018-01-08 |
Pharmacology for RITUXAN
| Mechanism of Action | CD20-directed Antibody Interactions |
Patent Text Search: US Patents for RITUXAN
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) | 2032-09-12 | RX | search | |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | Pharmacyclics LLC (Sunnyvale, CA) | 2030-06-03 | RX | search | |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for RITUXAN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 103393681 | Start Trial |
| Japan | 2011523697 | Start Trial |
| Taiwan | 201020248 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for RITUXAN
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 93138 | Luxembourg | Start Trial | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
| 300903 | Netherlands | Start Trial | PRODUCT NAME: INOTUZUMAB OZOGAMICIN; REGISTRATION NO/DATE: EU/1/17/1200 20170703 |
| LUC00074 | Luxembourg | Start Trial | PRODUCT NAME: ANTICORPS AFUCOSYLE SE LIANT AU RECEPTEUR ALPHA DE L'INTERLEUKINE-5, EN PARTICULIER LE BENRALIZUMAB OU UN VARIANT THERAPEUTIQUEMENT EQUIVALENT DE CELUI-CI, PROTEGE PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/17/1252 20180110 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
